Prudent Man Advisors LLC Grows Position in Healthpeak Properties, Inc. (NYSE:DOC)

Prudent Man Advisors LLC increased its position in Healthpeak Properties, Inc. (NYSE:DOC) by 20.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 11,129 shares of the real estate investment trust’s stock after purchasing an additional 1,879 shares during the quarter. Prudent Man Advisors LLC’s holdings in Healthpeak Properties were worth $226,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. HM Payson & Co. purchased a new position in shares of Healthpeak Properties in the 3rd quarter valued at approximately $25,000. Avior Wealth Management LLC purchased a new position in Healthpeak Properties during the third quarter valued at $37,000. Wiser Advisor Group LLC purchased a new position in Healthpeak Properties during the third quarter valued at $42,000. Capital Performance Advisors LLP purchased a new position in Healthpeak Properties during the third quarter valued at $42,000. Finally, Continuum Advisory LLC purchased a new position in Healthpeak Properties during the third quarter valued at $44,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

Shares of DOC opened at $20.44 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. Healthpeak Properties, Inc. has a one year low of $16.49 and a one year high of $23.26. The firm has a market capitalization of $14.30 billion, a P/E ratio of 58.39, a PEG ratio of 2.17 and a beta of 1.15. The business has a fifty day moving average of $20.19 and a 200 day moving average of $21.35.

Healthpeak Properties Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were issued a $0.305 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.22 annualized dividend and a dividend yield of 5.97%. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. Healthpeak Properties’s payout ratio is presently 348.57%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on DOC. Robert W. Baird lowered their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. Royal Bank of Canada lifted their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Wells Fargo & Company lowered their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Scotiabank lowered their price objective on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research note on Friday. Finally, Wedbush lowered their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, three have issued a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $23.92.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.